Kingdon Capital Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-100,000
Closed -$2.21M 115
2018
Q1
$2.21M Buy
+100,000
New +$2.76M 0.18% 93
2017
Q4
Sell
-100,000
Closed -$2.42M 125
2017
Q3
$2.42M Buy
+100,000
New +$2.66M 0.16% 89
2016
Q4
Sell
-1,100,700
Closed -$14.1M 135
2016
Q3
$14.1M Buy
+1,100,700
New +$11.9M 0.65% 41
2016
Q2
Sell
-400,000
Closed -$1.6M 109
2016
Q1
$1.6M Buy
+400,000
New +$1.69M 0.09% 97
2015
Q4
Sell
-100,000
Closed -$561K 123
2015
Q3
$561K Buy
+100,000
New +$544K 0.03% 125

Other funds holding EXEL

Kingdon Capital Management's EXEL Position: Q2 2018 in Review

Kingdon Capital Management sold out of Exelixis (EXEL) in Q2 2018, closing a stake of 352,659 shares — an estimated $7.81M sold.

Kingdon Capital Management first reported a position in EXEL in Q3 2015 and held it in 7 quarters. The position peaked at $7.92M in Q2 2016. 304 funds tracked by Wall St. Rank hold EXEL as of Q2 2018.

  • Kingdon Capital Management reported no remaining Exelixis position as of Q2 2018 after selling out during the quarter.
  • Kingdon Capital Management sold 352,659 Exelixis shares in Q2 2018, an estimated $7.81M.
  • Kingdon Capital Management first reported a position in Exelixis in Q3 2015 and held it in 7 quarters.
  • Kingdon Capital Management's Exelixis position peaked at $7.92M in Q2 2016.
  • 304 funds tracked by Wall St. Rank held Exelixis as of Q2 2018.

Based on Kingdon Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.